MARATTO

article · Journal of Experimental Biology and Agricultural Sciences

Ethnopharmacological study of medicinal plants used in the treatment of skin diseases in the Western Middle Atlas region (Morocco)

20242 citationsOpen accessIbn Tofail University

Abstract

An investigation was conducted among 360 people from the local population of the Western Middle Atlas of Morocco to identify medicinal plants used for treating skin diseases. Various parameters, including Relative Frequency of Citation (RFC), Family Use Value (FUV), Plant Part Value (PPV), Informant Consensus Factor (ICF), and Fidelity Level (FL), were used for data collection and assessment. During the investigation, 45 medicinal plant species belonging to 33 families were documented, with the most important family being Euphorbiaceae (FUV = 0.292). The highest ICF value (ICF=0.991) was mentioned for skin cancer. The poultice was found to be the primary method for preparing the majority of remedies (51%). Leaves were the most commonly used plant part (PPV = 0.476), and Allium sativum L. was the most widely used species (RFC = 0.302). These findings are a preliminary step towards conserving and popularising these plant species, promoting sustainable practices in traditional medicine, safeguarding biodiversity, and integrating these valuable botanical resources into modern healthcare systems.

Research topics

  • Ethnobotanical and Medicinal Plants Studies
  • Psidium guajava Extracts and Applications
  • African Botany and Ecology Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.18006/2024.12(1).93.105

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.